While TuHURA Biosciences Inc has underperformed by -11.97%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HURA fell by -74.82%, with highs and lows ranging from $6.11 to $1.14, whereas the simple moving average fell by -62.85% in the last 200 days.
On March 03, 2025, H.C. Wainwright started tracking TuHURA Biosciences Inc (NASDAQ: HURA) recommending Buy. A report published by Rodman & Renshaw on December 19, 2024, Initiated its previous ‘Buy’ rating for HURA. Maxim Group also rated HURA shares as ‘Buy’, setting a target price of $15 on the company’s shares in an initiating report dated November 05, 2024.
Analysis of TuHURA Biosciences Inc (HURA)
In order to gain a clear picture of TuHURA Biosciences Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -418.06% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.40, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 237.75K can be a very valuable indicator of volatility for HURA stock. On a monthly basis, the volatility of the stock is set at 13.54%, whereas on a weekly basis, it is put at 22.70%, with a loss of -46.07% over the past seven days. Furthermore, long-term investors anticipate a median target price of $8.50, showing growth from the present price of $1.03, which can serve as yet another indication of whether HURA is worth investing in or should be passed over.
How Do You Analyze TuHURA Biosciences Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 29.45%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 11.93% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
